All previous in vivo studies evaluating the effect of TREM2 deletion on tauopathy mouse models without the contribution of b-amyloid have been conducted in tau overexpression models; thus, the effect of TREM2 ablation on tau propagation remains unclear. The gene discussed is MAPT; the disease is tauopathy.